InsidersTradesSigma
Follow the 诚达药业 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 诚达药业 has published 1 reports. Market capitalisation: €4.2bn. The latest transaction was disclosed on 21 January 2022 (Sale). Among the most active insiders: 陈小红. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Chengda Pharmaceutical is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medicines.